Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44


Transient disorder: Calcineurin as an example.

Creamer TP.

Intrinsically Disord Proteins. 2013 Sep 19;1(1):e26412. doi: 10.4161/idp.26412. eCollection 2013 Jan-Dec. Review.


Expanding the PP2A Interactome by Defining a B56-Specific SLiM.

Wang X, Bajaj R, Bollen M, Peti W, Page R.

Structure. 2016 Dec 6;24(12):2174-2181. doi: 10.1016/j.str.2016.09.010. Epub 2016 Oct 27.


Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion Injury.

Hurt CM, Lu Y, Stary CM, Piplani H, Small BA, Urban TJ, Qvit N, Gross GJ, Mochly-Rosen D, Gross ER.

J Am Heart Assoc. 2016 Sep 26;5(9). pii: e003774.


Quercetin targets the interaction of calcineurin with LxVP-type motifs in immunosuppression.

Zhao Y, Zhang J, Shi X, Li J, Wang R, Song R, Wei Q, Cai H, Luo J.

Biochimie. 2016 Aug;127:50-8. doi: 10.1016/j.biochi.2016.04.011. Epub 2016 Apr 22.


Conformational Heterogeneity of Cyclosporin A in Cyclophilin 18 Binding.

Lin W, Quintero A, Zhang Y.

PLoS One. 2016 Apr 15;11(4):e0153669. doi: 10.1371/journal.pone.0153669. eCollection 2016.


SPLINTS: small-molecule protein ligand interface stabilizers.

Fischer ES, Park E, Eck MJ, Thomä NH.

Curr Opin Struct Biol. 2016 Apr;37:115-22. doi: 10.1016/ Epub 2016 Jan 30. Review.


Cooperative autoinhibition and multi-level activation mechanisms of calcineurin.

Li SJ, Wang J, Ma L, Lu C, Wang J, Wu JW, Wang ZX.

Cell Res. 2016 Mar;26(3):336-49. doi: 10.1038/cr.2016.14. Epub 2016 Jan 22.


Recent Advances Toward the Discovery of Drug-Like Peptides De novo.

Goldflam M, Ullman CG.

Front Chem. 2015 Dec 18;3:69. doi: 10.3389/fchem.2015.00069. eCollection 2015. Review.


Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus.

Falloon K, Juvvadi PR, Richards AD, Vargas-Muñiz JM, Renshaw H, Steinbach WJ.

PLoS One. 2015 Sep 14;10(9):e0137869. doi: 10.1371/journal.pone.0137869. eCollection 2015.


Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization.

Guasch A, Aranguren-Ibáñez Á, Pérez-Luque R, Aparicio D, Martínez-Høyer S, Mulero MC, Serrano-Candelas E, Pérez-Riba M, Fita I.

PLoS One. 2015 Aug 6;10(8):e0134569. doi: 10.1371/journal.pone.0134569. eCollection 2015.


Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors.

Mukherjee A, Syeb K, Concannon J, Callegari K, Soto C, Glicksman MA.

PLoS One. 2015 Jul 15;10(7):e0131297. doi: 10.1371/journal.pone.0131297. eCollection 2015.


Cyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinoma.

Chen J, Chen S, Wang J, Zhang M, Gong Z, Wei Y, Li L, Zhang Y, Zhao X, Jiang S, Yu L.

PLoS One. 2015 May 28;10(5):e0127668. doi: 10.1371/journal.pone.0127668. eCollection 2015.


Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.

Lee SC, Li A, Calo S, Inoue M, Tonthat NK, Bain JM, Louw J, Shinohara ML, Erwig LP, Schumacher MA, Ko DC, Heitman J.

Mol Microbiol. 2015 Sep;97(5):844-65. doi: 10.1111/mmi.13071. Epub 2015 Jun 17.


Viewing serine/threonine protein phosphatases through the eyes of drug designers.

Zhang M, Yogesha SD, Mayfield JE, Gill GN, Zhang Y.

FEBS J. 2013 Oct;280(19):4739-60. doi: 10.1111/febs.12481. Epub 2013 Sep 5. Review.


Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.

Gallay PA, Ptak RG, Bobardt MD, Dumont JM, Vuagniaux G, Rosenwirth B.

Viruses. 2013 Mar 22;5(3):981-97. doi: 10.3390/v5030981.


The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin.

Grigoriu S, Bond R, Cossio P, Chen JA, Ly N, Hummer G, Page R, Cyert MS, Peti W.

PLoS Biol. 2013;11(2):e1001492. doi: 10.1371/journal.pbio.1001492. Epub 2013 Feb 26.


Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

Rand AC, Leung SS, Eng H, Rotter CJ, Sharma R, Kalgutkar AS, Zhang Y, Varma MV, Farley KA, Khunte B, Limberakis C, Price DA, Liras S, Mathiowetz AM, Jacobson MP, Lokey RS.

Medchemcomm. 2012 Oct;3(10):1282-1289.


Calcineurin inhibition and new-onset diabetes mellitus after transplantation.

Chakkera HA, Mandarino LJ.

Transplantation. 2013 Mar 15;95(5):647-52. doi: 10.1097/TP.0b013e31826e592e. Review.


Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.

Zhao J, Yang P, Li F, Tao L, Ding H, Rui Y, Cao Z, Zhang W.

PLoS One. 2012;7(9):e44938. doi: 10.1371/journal.pone.0044938. Epub 2012 Sep 17.

Supplemental Content

Support Center